Gadolinium contrast: Farewell to well-known brands March 15, 2017 -- The long wait is over for the European Medicines Agency (EMA) investigation into gadolinium contrast agents. Its noncommittal verdict punishes all manufacturers, though some are given a sweetener, but it does not shed a complimentary light upon EMA, writes the Maverinck.
Monitoring software enables pediatric dose reduction March 15, 2017 -- The combination of dose-monitoring software and continuing education for radiographers/technologists can produce quantifiable reductions in radiation dose delivered to pediatric patients from conventional radiography studies, according to research presented at ECR 2017 in Vienna.
Dutch scoop top ECR prize for breast MRI work March 14, 2017 -- A new method may help improve delineation between malignant and benign breast lesions on breast MR images, according to researchers from the University of Groningen in the Netherlands. The group won a prestigious magna cum laude award at ECR 2017 in Vienna for its work.
Gap widens between CT innovation and installation March 13, 2017 -- Of all the major imaging modalities on show in the exhibition halls at ECR 2017, it's arguable that none have undergone such transformation over the last decade as CT. Following safety concerns and the increasing use of MRI and ultrasound, CT has had to reinvent itself, market analyst Stephen Holloway writes.
Pull linear MRI contrast from market, European group says March 10, 2017 -- In a stunning development, a European Union regulatory body on Friday recommended that four gadolinium-based contrast agents for MRI scans be pulled off the market due to concerns about gadolinium remaining in the body years after scans occur. The agents affected include some of the most widely used contrast products in medical imaging.
A step closer to Doc McCoy's beloved toy? March 10, 2017 -- The idea of handheld ultrasound is not a new one, with first-generation systems being available for almost a decade. These first devices were a marvel in shrinking ultrasound technology into a smartphone-sized device. But what about now? Market analyst Stephen Holloway addresses updates on the modality.
FDG-PET/CT can direct biopsies for pediatric cancer March 9, 2017 -- FDG-PET/CT can play a valuable role in directing image-guided biopsies of pediatric cancer patients, given its ability to detect and discern between malignant and benign regions, according to a study by a group from Saudi Arabia and Canada published in the March issue of the American Journal of Roentgenology.
Does breast MRI hold future for mammography market? March 8, 2017 -- Clinical evidence supporting the use of MRI for breast imaging is growing in volume and credibility. Further research is required, but evidence suggests MRI has a significant future role to play. So why have we seen little or no commercial impact from breast MRI? Market analyst Stephen Holloway reports.
8 ways radiology can win turf battles March 8, 2017 -- Turf battles in medicine are nothing new, and radiology is not alone in the struggle to protect territory. But how can radiology minimize conflict in a proactive rather than reactive manner? Dr. Christian Loewe from the Medical University of Vienna provides some solutions.
Top 5 trends from ECR 2017 in Vienna March 7, 2017 -- The stunning flower-and-skull display that formed the centerpiece of ECR 2017 certainly looked impressive in everybody's photos, on social media, and in the daily newspaper. But what were the truly lasting impressions and meaningful issues to take away from this year's congress in Vienna? Our editorial team has put together a list of five key themes.